DaVita Inc.
DVA evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for DVA—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$13.34B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run DaVita Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available DaVita Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
OCF $321M · Net income $198M · Debt/OCF 7.6×
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 6 sells (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
581
Total value held
$9.56B
| Holder | Shares | Value |
|---|---|---|
| berkshire hathaway inc | 30,100,585 | $4.63B |
| vanguard capital management llc | 4,360,450 | $670.2M |
| blackrock, inc. | 2,766,751 | $425.2M |
| morgan stanley | 1,666,038 | $256.1M |
| vanguard portfolio management llc | 1,479,600 | $227.4M |
| state street corp | 1,351,737 | $207.7M |
| dimensional fund advisors lp | 1,145,436 | $176.0M |
| arrowstreet capital, limited partnership | 1,110,151 | $170.6M |
| geode capital management, llc | 939,781 | $144.2M |
| woodline partners lp | 905,958 | $139.2M |
Showing top 10 of 581 institutional holders of DaVita Inc.. Open the full 13F history after sign-in.
Short Interest
as of Apr 19, 2026- % of float
- 20.2%
- Days to cover
- 6.9
- Shares short
- 6,182,715
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
DVA short interestGovernance
Frequently asked questions
Who is the CEO of DaVita Inc.?
Mr. Javier J. Rodriguez is the chief executive officer of DaVita Inc. (DVA).
Where is DaVita Inc. headquartered?
DaVita Inc. (DVA) is headquartered in Denver, CO, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.